Yin Li

Bioeconomy in China:

An Overview and Perspective

Institute of Microbiology, Chinese Academy of Sciences

yli@im.ac.cn

Evolution of the Chinese bioindustry and its policy support

Marked the beginning

of the modern

bioindustry in China

In 2006, development of

bioindustry became one of the top

priorities for the Chinese economy

Current status of the bioindustry

Chinese bioindustry is mainly

classified into seven major fields:

The total output value of China's

bioindustry was expected to hit:

RMB 4 trillion (US$ 630 billion) by the

end of 2015

RMB 8 trillion by the end of 2020

RMB 16 trillion by the end of 2030

0

2

4

6

8

10

12

14

16

2015 2020 2030

4

8

16

Trillion

RMB

The total output value of China' s

bioindustry in 2015-2030

Biomedicine

Biomedical engineering

Bio-agriculture

Bio-based manufacturing

Bioenergy

Bio-based environmental protection

Biotechnology service

annual growth rate of 22.9%

(56.9 trillion GDP in 2013, 3.5%)

Fields SubdivisionsOutput value

(RMB billion)

Biomedicine

Biotechnology medicine

2,100Chemical medicine

Traditional Chinese medicine

Biomedical

engineering

High-performance biomedical instruments

400Biomedical materials

Novel diagnostic products

Bio-agriculture

Bio-breeding

300Agro-bioproducts

Marine bioresources

Bio-based

manufacturing

Bio-based products including bio-based materials

750Bio-based chemicals and bulk fermentation products

Green bioprocesses

Bioenergy

Biomass electricity

150Biogas & biofuel

Biomass pellet

Bio-based environmental protection 150

Biotechnology services 150

Total 4,000

Subdivision of the bioindustry and

the expected annual output value by the end of 2015*

Patents in Chinese biotechnology from 2006 to 2015

In 10 years since 2006:

the number of biotechnology patents has continuously increased

the applied for and approved patents reached 22,193 (25.46% of global ones) and 10,394

(21.28%)

both ranked the second in the world

China's share of patents in the global biotechnology field also increased continuously

China's innovation capacity in the fields of life sciences and

biotechnology is continuously increasing

From 2013 to 2015, the output value maintained an average annual growth rate of over 20%

In 2010, the biological industry was listed as a strategic emerging industry, which marked the

beginning of its rapid development

In 2010, Decision of the State Council on Accelerating the Fostering and Development of Strategic

Emerging Industries was formally issued

In 2006, The State Council issued the National Medium and Long-term

Program for Science and Technology Development (2006-2020), in which

biotechnology was one of the important development directions

Till now

2011

2010

2006

In 2015, publications from China reached 87,765, second only to USA

The rank of publications from China in the world

the 8th in the world

the 4th in the world

the 2th in the world

the 2th in the world

67198382

994712350

15624

18770

22297

25798

0

5000

10000

15000

20000

25000

30000

2007 2008 2009 2010 2011 2012 2013 2014

Gro

ss in

du

stri

al o

utp

ut

valu

e

(RM

B 0

0,0

00

,00

0)

Year

Gross output value of national medical and

pharmaceutical industry from 2007 to 2014

Data source: (1) South Medicine Research Institute, 2014,

Blue Book on the Development of China's Medical and

Pharmaceutical Market in 2014; (2) Health Wealth Forum on

China's Medical and Pharmaceutical Industrial Chain in 2015.

From 2007 to 2014, the

gross output value of

medical and

pharmaceutical

industry stably grew in

China

Reached RMB 2,688.52

billion in 2015,

increased by 9.0%,

higher than the

national industrial

growth rate 8.2%

Biomedicine

Biomedical engineering

The sales of medical devices in China have continuously increased and reached

RMB 308 billion in 2015, almost 6 times the amount (RMB 53.5 billion) in 2007

High-performance

biomedical instruments

Biomedical

materials

Novel diagnostic

products

The sales of medical

devices in China have

continuously increased

and reached RMB 308

billion in 2015, almost 6

times the amount (RMB

53.5 billion) in 2007

China has now become globally the largest emerging market for in

vitro diagnostics.

The market scale is predicted to be about RMB 38.4 billion in 2018, with a compound annual growth rate of 17%

1 2 3

China's the market sales

amount in 2020 will be

US$ 120 billion, become

the second biggest

market of biomedical

materials, accounting for

22% of global market.

Bio-agriculture

biological breeding high-quality farm-oriented

biological products The Chinese government listed

transgenic breeding technology in the National High Technology Program, National Basic Research Programmefor R&D support

the bio-breeding industry has been listed as one of the Strategic Emerging Industries.

During the 12th "Five-Year Plan", China had obtained 137 critical genes with great breeding values, 1,036 patents, and a series of notable achievements including insect resistant cotton, insect resistant maize, and herbicide-resistant soybean

Biological

feeds

Biological

Pesticide

Veterinary

biological

products

Till the end of 2015, China had

registered 3,435,417 different

pesticides, 4,293 (with antibiotics)

biological pesticides involving 112

active ingredients

Over 1,000 enterprises in China

are dedicated towards production

and processing of feed additives

By the end of 2015, China had

registered 4,293 biological

pesticides involving 112 active

ingredients

Bio-based manufacturing

From the 12th "Five-Year Plan", the Chinese biological fermentation industry

generally maintained a stable developmental trend.

bio-based materials

bio-based chemicals

bulk fermentation products

green bioprocesses

bio-based products

The output of major bio-fermented

products:

amino acid: 3.7 million tons

organic acids: 2.1 million tons

Starch: 12 million tons

enzyme products: 1.2 million tons

fermented yeast: 0.32 million tons

functional fermented products: 3.4

million tons 18 million tons

2010

24.3 million tons

2015

Bioenergy

China is the third biggest country in the world producing and utilizing

bioethanol, second only to the USA and Brazil.

研究The bioethanol yield

in 2014 in China was

about 2 million tons

In 2014, COFCO and Sinopec group had developed

the whole set of production technology of cellulose

ethanol by using various raw materials with a yield

of 50,000 tons every year.

Shandong Longlive Biotechnology invested to

construct a project to comprehensively utilize 0.4

million tons of straw, which would produce 30,000

tons of cellulose ethanol every year.

Heilongjiang Jianye Fuel and Denmark Biofuel

Technology cooperated to construct a large

comprehensive utilization and processing base for

straw, which would produce 300,000 tons of

cellulose ethanol with straw every year.

China's biodiesel

industry is in the

growth phase

the total capacity of

biodiesel: 3-3.5

million tons

Bio-based environmental protection

Till 2015, annual output value of

biological environmental protection

reached RMB 150 billion

0.170.46

2.993.39

3.91

4.55

2000 2004 2012 2013 2014 2015

OUTPUT VALUE (RMB OOO BILL ION)

Output value (RMB OOO billion)

Output Values of

Environmental Protection

Industry in China in 2000-2015

Development of biological environmental

protection industry in China has the

following 3 characters:

1. Environmental protection

industry is continuously increasing

2. Biological environmental

protection technology and products

continuously improves

3. Environmental service industry

develops relatively quickly

Biotechnology service

In 2015, annual output value of biological service industry

reached RMB 150 billion.

• CMO industry in the

development phase

• The market value will

be over RMB 30

billion in 2017

• The average annual

growth rate 17.4%

from 2012 to 2017

• the CRO market value

in China was only

RMB 4.8 billion in

2007 and about RMB

38 billion in 2015

• started relatively late

• WuXi AppTec, Shang

Pharma, Tigermed,

and Boji

Pharmaceutical

marking the gradual

rise of the industry

CRO industry CMO industryCRO market

Strategies and approaches for advancing

bioindustry development

Introducing talent and

intelligence

Increasing policy

support

Strengthening

innovation capacity

Strengthening

international

collaboration

Increasing capital

investment

Thank you